PharmaCielo Ltd.
PCLO.V
TSX
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 127.22% | 48.09% | 50.03% | 77.16% | 5.83% |
| Total Depreciation and Amortization | 52.35% | -66.25% | -94.23% | -22.30% | -107.69% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -77.15% | -36.48% | -32.43% | -72.64% | 62.96% |
| Change in Net Operating Assets | -3,712.04% | -46,664.15% | 934.46% | -98.46% | -103.48% |
| Cash from Operations | 377.28% | -532.39% | 445.85% | 87.57% | 40.51% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -100.00% |
| Cash from Investing | -- | -- | -- | -- | -100.00% |
| Total Debt Issued | -71.04% | -95.88% | -85.43% | -71.46% | -100.00% |
| Total Debt Repaid | 151.18% | -5,280.50% | -492.20% | 41.52% | 8.46% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -20.60% | -769.73% | -552.70% | -78.99% | -31.66% |
| Foreign Exchange rate Adjustments | 188.89% | 1,783.33% | 54.55% | -131.40% | 16.67% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -73.29% | 1,828.57% | 65.77% | 213.98% | 82.67% |